Investor Relations
News ReleasesRSS
- Feb 13, 2019 Chugai’s Actemra, the World’s First Anti-IL-6 Receptor Antibody Created in Japan, Wins Chairman’s Award of Japan Techno-Economics Society
- Feb 12, 2019 Chugai Wins Second Prize in 21st NIKKEI Annual Report Awards
- Feb 06, 2019 Together with Roche, Chugai Joins the World Federation of Hemophilia Humanitarian Aid Program
- Feb 05, 2019 The 1st Japan Open Innovation Prize: Four Parties including Osaka University Win the Minister of Education, Culture, Sports, Science and Technology Award for “University-Industry Co-creation from the Basic Research Stage -Collaboration between Organizations-”
- Feb 04, 2019 Chugai’s Hemlibra® Gains Positive CHMP Opinion in Severe Hemophilia A without Inhibitors
What's NewRSS
- Feb 04, 2019 Webcast of Investor Conference on FY 2018.12 Financial Results
- Feb 01, 2019 Investor Conference on FY 2018.12 Financial Results
- Jan 31, 2019 Financial Results for the Fiscal Year ended December 2018
- Jan 09, 2019 Events & Presentations has been updated with the Date of the Financial Results for 2018 FY
- Dec 17, 2018 The dates of the Financial Results for 2018 FY, 2019 Q1, Q2, and Q3 have been updated.
